Drug Shortage Report for CEFUROXIME FOR INJECTION, USP

Last updated on 2020-01-16 History
Report ID 51500
Drug Identification Number 02241640
Brand name CEFUROXIME FOR INJECTION, USP
Common or Proper name Cefuroxime
Company Name FRESENIUS KABI CANADA LTD
Market Status DORMANT
Active Ingredient(s) CEFUROXIME
Strength(s) 7.5G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 7.5g
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-06-01
Estimated end date Unknown
Actual end date 2018-08-07
Shortage status Resolved
Updated date 2020-01-16
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-01-16 French Compare
v3 2020-01-16 English Compare
v2 2018-06-05 French Compare
v1 2018-06-05 English Compare